Skip navigation
All CNBC  |  News  |  Video


CNBC TV Profiles
Mike Huckman
MIKE HUCKMAN
CNBC Pharmaceuticals Reporter


Mike Huckman is CNBC's Pharmaceuticals Reporter covering the drug, biotechnology and medical device industries. Huckman is based at the network’s global headquarters in Englewood Cliffs, N.J.

Huckman joined CNBC in September 2000 after nine years at WXYZ-TV in Detroit where he was one of the station’s lead reporters. Prior to WXYZ-TV, he served as a general assignment reporter at KGUN-TV in Tucson, Ariz., KBCI-TV in Boise, Idaho, and as an anchor/producer for the Montana Television Network.

Huckman has won numerous awards for his reporting, including three Michigan News Emmys, one for Business and Financial reporting, as well as a first place News Series Award from the Michigan Association of Broadcasters.

Huckman earned a Bachelor of Arts degree in journalism from the University of Southern California.


LATEST VIDEO


Current DateTime: 06:39:55 25 Nov 2009
LinksList Documentid: 24259411
CNBC TV PROGRAMS

ANCHORS, REPORTERS & CONTRIBUTORS


PHARMA'S MARKET WITH MIKE HUCKMAN


Current DateTime: 06:39:56 25 Nov 2009
LinksList Documentid: 24259406
    • Novartis 'Cells' Its Flu Vaccine Technology 24 Nov 2009

        For the second time in three weeks I'm at a flu vaccine manufacturing plant today. Construction isn't finished on the Novartis site yet, but nonetheless they're doing the formal ribbon-cutting ceremony here in Holly Springs, NC this afternoon.

    • May Day For Dendreon 20 Nov 2009

        Investors, patients and activists, no doubt, hope they won't have to put out a mayday distress call, but as Dendrama's fate would have it, the company announced today that the Food and Drug Administration has assigned May Day as its decision day for the prostate cancer treatment Provenge.

    • Do We Need An Arbiter? 20 Nov 2009

        Earlier this week I reported that Dr. Allen Taylor who ran the Abbott vs. Merck cholesterol drug study, which Abbott's drug Niaspan won, would only say that ABT has paid him more than $10,000 in lecture and consulting fees. But he wouldn't be any more specific than that.

    • Vivus Viagra! 18 Nov 2009

        VVUS this morning unveiled positive late-stage test results on the ED pill. The company touts that it takes effect in less than 30 minutes and it's out of your system within six hours or so.

    • Abbott, Arbiter & Avoidance 17 Nov 2009

        When I do an interview with a clinical trial investigator I typically try to take care of what I call the "housekeeping" at the beginning or end.

    • Getting to the Heart of the Merck-Abbott Embargo Break 16 Nov 2009

        Live TV is best when things are happening and news is breaking right now. It's immediate and often, hopefully, more compelling.


Current DateTime: 12:56:53 25 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 10:38:03 25 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 04:32:22 25 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 10:38:03 25 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters